中文 | English
Return
Total: 266 , 1/27
Show Home Prev Next End page: GO
Author:(Ling Jia ZHOU)

1.Research progresses of endogenous vascular calcification inhibitor BMP-7

Xin ZHOU ; Lu XING ; Peng-Quan LI ; Dong ZHAO ; Hai-Qing CHU ; Chun-Xia HE ; Wei QIN ; Hui-Jin LI ; Jia FU ; Ye ZHANG ; Li XIAO ; Hui-Ling CAO

Chinese Pharmacological Bulletin 2024;40(7):1226-1230

2.Temporal trend of the global prevalence rate of tension-type headache in children and adolescents in 1990-2021

Ling-Zi YAO ; De-Nan JIANG ; Jing WU ; Guang-Dian SHEN ; Jin CAO ; Si-Qing CHENG ; Shi-Yi SHAN ; Ze-Yu LUO ; Jia-Li ZHOU ; Pei-Ge SONG

Chinese Journal of Contemporary Pediatrics 2024;26(10):1058-1065

3. The molecular mechanism of spleen-strengthening and moisture-nourishing liver prescription in treatment of acute-on-chronic liver failure based on network pharmacology and experimental verification

Qi HUANG ; Wen-Feng MA ; Zhi-Yi HAN ; Jia-Ling SUN ; Wei ZHANG ; Xin-Feng SUN ; Jian -Ping CHEN ; Xiao-Zhou ZHOU ; Qi HUANG ; Wen-Feng MA ; Zhi-Yi HAN ; Jia-Ling SUN ; Wei ZHANG ; Xin-Feng SUN ; Xiao-Zhou ZHOU ; Jing LI ; Xiao-Zhou ZHOU ; Jian -Ping CHEN

Chinese Pharmacological Bulletin 2024;40(3):557-564

4.Discussion of the methodology and implementation steps for assessing the causality of adverse event

Hong FANG ; Shuo-Peng JIA ; Hai-Xue WANG ; Xiao-Jing PEI ; Min LIU ; An-Qi YU ; Ling-Yun ZHOU ; Fang-Fang SHI ; Shu-Jie LU ; Shu-Hang WANG ; Yue YU ; Dan-Dan CUI ; Yu TANG ; Ning LI ; Ze-Huai WEN

The Chinese Journal of Clinical Pharmacology 2024;40(2):299-304

5.Clinical trial of Morinda officinalis oligosaccharides in the continuation treatment of adults with mild and moderate depression

Shu-Zhe ZHOU ; Zu-Cheng HAN ; Xiu-Zhen WANG ; Yan-Qing CHEN ; Ya-Ling HU ; Xue-Qin YU ; Bin-Hong WANG ; Guo-Zhen FAN ; Hong SANG ; Ying HAI ; Zhi-Jie JIA ; Zhan-Min WANG ; Yan WEI ; Jian-Guo ZHU ; Xue-Qin SONG ; Zhi-Dong LIU ; Li KUANG ; Hong-Ming WANG ; Feng TIAN ; Yu-Xin LI ; Ling ZHANG ; Hai LIN ; Bin WU ; Chao-Ying WANG ; Chang LIU ; Jia-Fan SUN ; Shao-Xiao YAN ; Jun LIU ; Shou-Fu XIE ; Mao-Sheng FANG ; Wei-Feng MI ; Hong-Yan ZHANG

The Chinese Journal of Clinical Pharmacology 2024;40(6):815-819

6.Anti-glioblastoma study of YHP-836, a novel PARP1/2 inhibitor, in combination with temozolomide

Jia-ling DENG ; Ting-ting DU ; Jie ZHOU ; Bai-ling XU ; Xiao-guang CHEN ; Ming JI

Acta Pharmaceutica Sinica 2024;59(6):1656-1663

7.Effects of Quorum Sensing Molecules on The Immune System

Wen-Min MA ; Xuan-Qi CHEN ; Hong-Xia MA ; Wen-Hui ZHANG ; Ling-Cong KONG ; Yu-Jia ZHOU ; Yuan-Yuan HU ; Yu JIA

Progress in Biochemistry and Biophysics 2024;51(11):2853-2867

8.The expression mechanism of programmed cell death 1 ligand 1 and its role in immunomodulatory ability of mesenchymal stem cells

Zhuo CHEN ; Meng-Wei YAO ; Xiang AO ; Qing-Jia GONG ; Yi YANG ; Jin-Xia LIU ; Qi-Zhou LIAN ; Xiang XU ; Ling-Jing ZUO

Chinese Journal of Traumatology 2024;27(1):1-10

9.Migraineur patent foramen ovale risk prediction model for female migraine patient streaming and clinical decision-making

Xiao-Chun ZHANG ; Jia-Ning FAN ; Li ZHU ; Feng ZHANG ; Da-Wei LIN ; Wan-Ling WANG ; Wen-Zhi PAN ; Da-Xin ZHOU ; Jun-Bo GE

Fudan University Journal of Medical Sciences 2024;51(4):505-514

10.Anti-Tumor Effect and Mechanism of Yiqi Tongqiao Prescription on Nasopharyngeal Carcinoma in Nude Mice

Xue-Yan CHANG ; Ling ZHOU ; Jia-Peng YANG ; Jing-Dan LIU

Journal of Guangzhou University of Traditional Chinese Medicine 2024;41(9):2426-2432

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 266 , 1/27 Show Home Prev Next End page: GO